The New Zealand sharemarket, dictated by the volatile Fisher and Paykel Healthcare stock, posted another small decline and ...
Medical device maker Fisher & Paykel Healthcare faces a significant impact from potential tariffs in the US, say research ...
It’s shaping up as a big year for late-stage Australian-listed drug developers, with analysts tipping potentially hefty share ...
The top 10 Australian share funds of 2024 have been revealed, with the reigning champion retaining its crown for a second straight year, according to a Mercer investment survey.
US tariffs could mean a $46 million hit to Fisher & Paykel Healthcare’s profit in a worst-case scenario, analysts say. A ...
New Zealand-listed shares have underperformed compared to many global markets with greater exposure to tech sector gains, ...
1 Day FPH -2.37% DJIA -0.32% S&P 500 -0.29% Health Care/Life Sciences -0.58% ...
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Stockhead on MSN6d
Health Check: Did the earth move for you? The world shifts on its axis as it enters the Trump era mark twoThe day that many thought would never come has dawned: the big orange one now presides over the red button as Commander in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback